Overview

Trial to Evaluate the Sirolimus-Eluting Collagen Implant on AV Fistula Outcomes

Status:
Completed
Trial end date:
2021-06-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate efficacy and safety outcomes following use of the Sirolimus-eluting Collagen Implant (SeCI) in subjects undergoing surgical creation of an AV fistula for vascular access (index procedure).
Phase:
Phase 3
Details
Lead Sponsor:
Vascular Therapies, Inc.
Treatments:
Everolimus
Sirolimus